Bharat Forge reported consolidated revenue growth of 12.4% for Q2 FY27, led by its Pharmaceutical division, which contributed 19.1% of the total. Operating margin held at 11.2%, a few basis points below the previous quarter as higher logistics and wage costs offset operating leverage.
A new long-term agreement with Infosys anchors a portion of the expansion. The deal covers multi-year supply at index-linked pricing, with volume commitments that provide a floor, and includes a joint development programme for higher-specification products with better margins.
The numbers
The company also announced a new facility near Hazira, designed to add about 838 tonnes of annual capacity and create roughly 1,200 jobs. Construction begins next quarter, and first production is targeted within 20 months. The plant will be built to meet European environmental standards.
Analysts were broadly constructive. Of 18 brokerages covering the stock, 12 maintain buy ratings, with target prices implying about 19.1% upside. The more cautious voices pointed to a valuation premium and the execution risk inherent in a large expansion programme.
By the numbers
Balance-sheet metrics remain comfortable. Net debt to earnings stood at 0.8 times, and the company retired $281 million of high-cost borrowings during the quarter. Credit analysts say the improvement leaves room to fund the expansion without equity dilution.
“Visibility is worth more than growth. We can plan investments when we can see 14 months ahead.”
Expansion and capital allocation
Export performance was a bright spot. Shipments to UAE rose 12.4%, helped by certification wins and shorter lead times from Hazira. Management said it would deepen its presence in the market by adding a local warehouse and a technical service team.
Source: IGEN Intelligence analysis of un comtrade data. Illustrative mock data.
Capital expenditure guidance was raised to $1.7 billion for the fiscal year, from $281 million previously. Management said the increase reflects accelerated spending on automation and on debottlenecking existing lines, which it expects to deliver 11.2% more output without additional land.
| Segment | Revenue | YoY | Margin |
|---|---|---|---|
| Pharmaceutical (core) | $519M | +17% | 15.8% |
| Exports | $520M | -2% | 19.3% |
| Domestic retail | $453M | +12.7% | 24.9% |
| Services | $367M | +15.5% | 13.9% |
| Other | $116M | +0.7% | 19% |
Customers, contracts and exports
Employees and communities are part of the plan: a skills academy near the new site will train 2,000 technicians over three years, funded jointly with the state government. Management said local hiring is a condition of the incentives it has received.
Timeline of key events
- Results announced
Revenue up 12.4%; margin steady at 11.2%.
- Capex raised
Guidance moves to $1.7 billion to fund automation and debottlenecking.
- Supply pact signed
Multi-year agreement with Infosys at index-linked pricing.
- Groundbreaking
Construction at the new facility near Hazira begins.
- First production
Targeted within 20 months of groundbreaking.
Risks were not ignored. Executives flagged input-cost volatility, potential delays in environmental clearances for the new plant and the possibility of tougher competition from lower-priced imports. They said a pricing-pass-through mechanism covers about 60 percent of exposure.
Expert commentary
“The pact is not just volume; it is a joint roadmap for higher-value products.”
“In my conversations with procurement heads, reliability is mentioned three times for every mention of price.”
“Buyers are paying a premium for certainty. Suppliers who can document, deliver and communicate will capture it.”
Risks and analyst view
On the post-results call, management said the order book now stands at $1.7 billion, equivalent to roughly 14 months of revenue, with about a third from export customers in UAE and South Korea. The chief financial officer described visibility as the best in five years.
What it means for you
Order visibility and a manageable balance sheet support the story; track execution on the new plant and margin pass-through.
Expansion will lift procurement; engage early on qualification for the new lines.
Longer-term agreements offer price stability in exchange for volume commitments; compare index-linked terms carefully.
About 1,200 direct roles and a technician academy are planned near Hazira; applications open with the state skills portal.
Companies and leaders in this story
Frequently asked questions
Sources
- UN Comtrade: Bilateral trade flows by HS code
- Port authority statistics: Container volumes, dwell times and berth productivity
- Company filings and earnings calls: Disclosures on order books and capex
- Ministry of Commerce & Industry: Monthly trade statistics and notifications
Mock content for demonstration. Names, figures and quotes are illustrative and not real reporting.
